A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19

Journal:

Nature Communications

Published:

2025-10-14

DOI:

10.1038/s41467-025-63972-4

Affiliations:

9

Authors:

18

Go to article

Institutions	Authors	Share
AstraZeneca Gaithersburg, MD, United States of America (USA)	10.000000 10.000000	0.56
AstraZeneca Cambridge, United Kingdom (UK)	6.000000	0.33
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	1.000000	0.06
Fred Hutchinson Cancer Center, United States of America (USA)	1.000000	0.06

Interested in Immunology?